Default: Vascular Medicine

ISSN: 1358-863X

Journal Home

Journal Guideline

Vascular Medicine Q1 Unclaimed

SAGE Publications Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Vascular Medicine is a journal indexed in SJR in Medicine (miscellaneous) and Cardiology and Cardiovascular Medicine with an H index of 86. It has a price of 2395 €. It has an SJR impact factor of 0,959 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,959.

Vascular Medicine focuses its scope in these topics and keywords: peripheral, critical, disease, embolism, healthcare, limb, longterm, patient, pulmonary, aging, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

2395 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Vascular Medicine

0,959

SJR Impact factor

86

H Index

117

Total Docs (Last Year)

309

Total Docs (3 years)

2622

Total Refs

604

Total Cites (3 years)

209

Citable Docs (3 years)

1.78

Cites/Doc (2 years)

22.41

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


peripheral, critical, disease, embolism, healthcare, limb, longterm, patient, pulmonary, aging, amputationfree, ankle, aorta, brachial, bypass, cancercocaine, cardiovascular, challengeshort, change, continuum, current, delivery, diagnosing, differences, diseasedepression, dissectiondifficulties, extremity, including, index, information, integrated,



Best articles by citations

Acute aortic syndrome: a case presentation and review of the literature

View more

Percutaneous revascularization of persistent renal artery in-stent restenosis

View more

Presidential address

View more

Fibrinogen - marker or mediator of vascular disease?

View more

Embracing a new paradigm to sustain vascular medicine

View more

Mesenteric arterial ischaemia: diagnosis and therapeutic options

View more

The S curve: A novel morphological finding in the internal carotid artery in patients with fibromuscular dysplasia

View more

Perspective

View more

Troponin T, NT-proBNP, and venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)

View more

Physical training for intermittent claudication: a comparison of structured rehabilitation versus home-based training

View more

High incidence and clinical characteristics of fibromuscular dysplasia in patients with spontaneous cervical artery dissection: The ARCADIA-POL study

View more

Knowledge of peripheral artery disease: What do the public, healthcare practitioners, and trainees know?

View more
SHOW MORE ARTICLES

Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system

View more

Asymmetric dimethylarginine (ADMA) modulates endothelial function - therapeutic implications

View more

Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure

View more

Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial

View more

Deferoxamine-fibrin accelerates angiogenesis in a rabbit model of peripheral ischemia

View more

Pharmacologic treatment for intermittent claudication

View more

Variability of flow-mediated dilation measurements with repetitive reactive hyperemia

View more

Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes

View more

A curious cause of bilateral upper extremity lymphedema: 'Puffy hand syndrome'

View more

Oral L-arginine improves endothelial function in healthy individuals older than 70 years

View more

Plasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults

View more

Impact of diabetes mellitus on 5-year clinical outcomes following successful endovascular revascularization for peripheral artery disease

View more

FAQS